Sainabou Jallow, MBCHB

Sainabou Jallow practices at Unity Hospital - Unit in Rochester, New York.

Sainabou Jallow's NPI, 1306193214, was assigned on August 9, 2012. Sainabou Jallow graduated from University of Science and Technology School of Medicine in 2005. Sainabou Jallow holds New York license 287616.

Sainabou Jallow's primary practice is Unity Hospital - Unit, at 1555 Long Pond Rd, Rochester, NY 14626 in Monroe County. The practice phone is (585) 368-3002.

Sainabou Jallow's primary practice is Unity Hospital - Unit in Rochester, New York. Sainabou Jallow is also affiliated with Rochester General Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Sainabou Jallow to 4 more hospitals, 5 medical groups and 1 hospice, each named with a free account. Sainabou Jallow's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Sainabou Jallow practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Sainabou Jallow's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Sainabou Jallow's licenses on file in 2 states: New York and Minnesota.

CMS data shows 336 Medicare services from Sainabou Jallow across 4 procedure codes in 2024, for 107 Medicare patients. Medicare paid $29,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Sainabou Jallow in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sainabou Jallow's median patient age at 77, with 59% women.

In 2024, Sainabou Jallow wrote 162 Medicare Part D claims for 80 patients. 91% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $5,168 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Sainabou Jallow for performance year 2024, reported through an alternative payment model (APM). Sainabou Jallow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Sainabou Jallow from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $17.

Sainabou Jallow graduated from University of Science and Technology School of Medicine in 2005.